Premium Information is available for this item - Upgrade for $1 a day
6505-01-425-1095
Usp Lidocaine Hydrochloride Injection
6505014251095 014251095 NDC0548-1190-00 1190
INC: 10155 Lidocaine Hydrochloride Injection
January 2023
6
Marketplace 6505-01-425-1095
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-425-1095 2+ Documents (More...)
Every Day 6505-01-425-1095 RQST NE Updated Every Day 6505-01-425-1095 RQST Updated Every Day 6505-01
/fsg-65/fsc-6505/us 6505-01-425-1095 Usp Lidocaine Hydrochloride Injection NDC0548-1190-001190 Managed
www.nsnlookup.com 190032237 6505/uk 6505-99-417-8306 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-425-1095
Usp Lidocaine Hydrochloride Injection Hydrochloride Injection NDC0548-1190-001190 Managed https
Restrictions 6505-01-425-1095
6505-01-425-1095 is a Usp Lidocaine Hydrochloride Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-425-1095
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-425-1095
- Singapore (YJ01)
- Effective Date:
- 1 Nov 2006
- United Kingdom (ZK01)
- Effective Date:
- 1 Feb 1996
Approved Sources 6505-01-425-1095
- Part Number
- Manufacturer
- Status
- NDC0548-1190-00
- Manufacturer
- 54536 - International Medication Systems, (Active)
- Primary Buy
- Primary Buy
- 1190
- 54536 - International Medication Systems, (Active)
- Primary Buy
- Primary Buy
- 1190
- K1F14 - Medeva Pharma Ltd (Replaced)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-425-1095
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Special Features [FEAT]
- 2 Pct Concentration; 5 Ml Vial
Similar Supply Items to 6505-01-425-1095
Freight Information 6505-01-425-1095
6505-01-425-1095 has freight characteristics.. 6505-01-425-1095 has a variance between NMFC and UFC when transported by rail and the description should be consulted.